MACRO
BRENTWTINAT GASGOLDSILVERPLATINUMPALLADIUMGOLD/SILVERCOPPERGASOLINECOCOAOJCANOLAS&P 500NASDAQDXYFED RATEBTCTASIDFMADXBRENTWTINAT GASGOLDSILVERPLATINUMPALLADIUMGOLD/SILVERCOPPERGASOLINECOCOAOJCANOLAS&P 500NASDAQDXYFED RATEBTCTASIDFMADX
40

Dr. Soliman Abdul Kader Fakeeh

4017XSAU
Saudi Exchange·Healthcare
SAR 34.36
▼︎ 3.16%(-1.12)
Pre-Market
Updated yesterday
Data as of 13 May 2026
Open
SAR 35.08
High
SAR 35.16
Low
SAR 34.32
Volume
165.8K
52W High
SAR 47.15
52W Low
SAR 27.20
1W
-4.82%
1M
-4.34%
3M
+8.46%
6M
-0.12%
YTD
-0.12%
1Y
-13.67%

Mīzān Analysis

21/60

Mixed signals — review dimensions carefully

Value3.6Growth2.4Health4.8Income0.0Momentum8.4Sentiment7.0
4017Sector
Market Cap
8.4B SAR
P/E
28.1
Revenue Growth
7.6%
Div Yield

Rewards

No standout positive signals at current scores.

Risk Analysis

No significant risk flags at current scores.

Scores computed 13 May 2026

Fundamentals

Market Cap
8.4B SAR
P/E Ratio
28.14
P/B Ratio
2.65
EPS
SAR 1.30
EPS Growth
-13.0%
Revenue
2.8B SAR
Revenue Growth
7.6%
Net Income
263.7M SAR
Profit Margin
9.4%
Debt / Assets
0.20
Dividend Yield
Dividend Per Share
SAR 0.00
Shares Outstanding
230.0M
Reporting Period: 2024-12-31Data as of May 1, 2026

Mizān Summary

News

Sector News10Industry & macro context
Trade ministers discuss final steps for GCC-UK FTA
Qatar Tribune· 1 day agoNeutralEconomy
UAE launches global plan to reach 42 million people, eradicate river blindness by 2030
Economy Middle East· 3 days agoNeutral
UAE Business: PureHealth surpasses $1.72bn in local procurement spend
Gulf Daily News· 7 days agoEconomy
Bahrain SWF Mumtalakat, SandboxAQ to boost Bahrain’s biotech sector
MSN· 12 days agoNeutralEconomy
Abu Dhabi’s PureHealth Q1 2026 revenue rises 10 percent to $2 billion on global expansion
Economy Middle East· 13 days agoNeutral
Omani delegation visits China to explore high tech pharmaceutical and medical ventures
Times of Oman· 16 days agoNeutralEconomy
Memo to enhance training, employment in pharmaceutical industry inked
وكالة الانباء الاردنية· 23 days agoNeutralEconomy
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
CNBC Business· 27 days agoNeutralMarket Movers
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
CNBC Business· 28 days agoPositiveMarket Movers
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides
MarketWatch Top Stories· 28 days agoPositiveEconomy

Events

No upcoming corporate events